Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2026)

Amneal Pharmaceuticals has reported Assets Average for 9 years, with the latest figure at $3.7 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 7.79% year-over-year to $3.7 billion in Q2 2026; TTM through Jun 2026 was $3.7 billion, a 7.79% increase from a year earlier, with the FY2025 full-year figure at $3.6 billion, up 2.95% from the prior year.
• Assets Average was $3.7 billion for Q2 2026 at Amneal Pharmaceuticals, up from $3.6 billion in the prior quarter.
• The five-year high for Assets Average was $4.0 billion in Q2 2022, with the low at $3.4 billion in Q2 2025.
• Average Assets Average over 5 years is $3.6 billion, with a median of $3.6 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2026: Assets Average fell 7.6% in 2023, then increased 7.79% in 2026.
• Over 5 years, Assets Average stood at $3.8 billion in 2022, then dropped by 6.69% to $3.6 billion in 2023, then retreated by 2.75% to $3.5 billion in 2024, then gained by 4.53% to $3.6 billion in 2025, then advanced by 0.53% to $3.7 billion in 2026.
• The last three Assets Average figures came in at $3.7 billion (Q2 2026), $3.6 billion (Q1 2026), and $3.6 billion (Q4 2025), per Business Quant data.